IAV infection suppresses tumour growth dose dependently. by Philine Steinbach (17847521)

Synthetic Control of Excited-State Properties in Cyclometalated Ir(III) Complexes Using Ancillary Ligands by Jian Li (41607)

“…The Ir−C_aryl bond lengths in (<i>tpy</i>)₂Ir(CN-<i>t-</i>Bu)₂⁺ (2.047(5) and 2.072(5) Å) and (<i>tpy</i>)₂Ir(PPh₂CH₂)₂BPh₂ (2.047(9) and 2.057(9) Å) are longer than their counterparts in (<i>tpy</i>)₂Ir(acac) (1.982(6) and 1.985(7) Å). …”

Synthetic Control of Excited-State Properties in Cyclometalated Ir(III) Complexes Using Ancillary Ligands by Jian Li (41607)

“…The Ir−C_aryl bond lengths in (<i>tpy</i>)₂Ir(CN-<i>t-</i>Bu)₂⁺ (2.047(5) and 2.072(5) Å) and (<i>tpy</i>)₂Ir(PPh₂CH₂)₂BPh₂ (2.047(9) and 2.057(9) Å) are longer than their counterparts in (<i>tpy</i>)₂Ir(acac) (1.982(6) and 1.985(7) Å). …”

Quality as a function of coverage, according to theoretical model. by Melissa J. Hubisz (51880)

“…The solid black curve shows that expected sequence quality increases nearly linearly with expected coverage, at a rate of ∼3.62 <i>phred</i> units per additional 1× of coverage, corresponding to a 10−3.62/lO≈43% decrease in the error rate. …”

Discovery of Dual-Acting Biofilm Inhibitors against Pseudomonas aeruginosa by the Coupling of 3‑Hydroxypyridin-4(1<i>H</i>)‑ones with <i>N</i>‑Phenylamide QS Inhibitors by Hao-Zhong Long (19685972)

Effects of Intralipid on hepatic PPAR_β/δ mRNA expression in SD rats. by Lu Zheng (132726)

Probing the Histamine H₁ Receptor Binding Site to Explore Ligand Binding Kinetics by Sebastiaan Kuhne (1474948)

“…Ligand efficiency (LE) decreases upon the introduction of the negatively charged group, whereas kinetic efficiency (KE) increases up to 8.5-fold. …”

Probing the Histamine H₁ Receptor Binding Site to Explore Ligand Binding Kinetics by Sebastiaan Kuhne (1474948)

“…Ligand efficiency (LE) decreases upon the introduction of the negatively charged group, whereas kinetic efficiency (KE) increases up to 8.5-fold. …”

miR-UL112-3p inhibits TLR2-dependent activation of the NFκB pathway in THP1 cells. by Igor Landais (2213320)

“…<p>(A) Schematic of cell treatment. THP1 or NFκB luciferase reporter THP1 cells (THP1-NFκBRE-luc) were transfected with siRNA or miRNA mimics after being differentiated for 24hrs with TPA. …”

TLR2 3’UTR is targeted by HCMV miRNAs. by Igor Landais (2213320)

Transient Pinning and Pulling: A Mechanism for Bending Microtubules by Ian A. Kent (3179607)

“…This suggests that dynein generates a tangential force that bends microtubules against stationary pinning points. …”

Supplementary file 1_Early life predictors of child development at kindergarten: a structural equation model using a longitudinal cohort.docx by Sarah E. Turner (8478309)

“…Higher SES was related to a-0.26 (p-value =0.01) standardized decrease of EDI vulnerability, and this link was partially mediated through family stress at 3 years (10.6% mediated). …”

Quantitatively describing the downstream effects of an abrupt land cover transition: buffering effects of a forest remnant on a stream impacted by cattle grazing by Rafael Feijó-Lima (5666879)

Generation of the parenchyma-fluid-interface (PFI) mask. by Juliana Zimmermann (10507091)

The N-terminal low complexity and PUF domains of Puf3 are critical for interaction with Pbp1. by Floortje van de Poll (15810877)

“…Transcript levels are shown in <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1010774#pgen.1010774.s005" target="_blank">S5 Fig</a>.…”

<i>Chlamydia trachomatis</i> Pgp3 Antibody Population Seroprevalence before and during an Era of Widespread Opportunistic Chlamydia Screening in England (1994-2012) by Sarah C. Woodhall (448596)

“…A decrease in age-specific cumulative incidence following national implementation of opportunistic chlamydia screening has not yet been demonstrated. …”

Pharmacodynamic Effects of Canagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, from a Randomized Study in Patients with Type 2 Diabetes by Sue Sha (622956)

“…Canagliflozin dose-dependently decreased RT_G, with maximal reductions to ∼4–5 mM (72–90 mg/dL). …”

The difference in outcome parameters between groups. by Mi-yeon Yu (813778)

“…<p>Outcome parameters represent the followings; O1, decrease of time-averaged proteinuria from trial phase and to the observational phase; O2, remission of UPCR <0.2 g/g cr during observational phase; O3, rapid decline of eGFR ≥5 mL/min/1.73 m² during observational phase; O4, composite outcome of increase in serum cr level (≥50% from baseline) noted during observational phase or deterioration of renal function to end stage renal disease. …”

CD8⁺ T-cells are essential for tumour growth suppression during IAV infection. by Philine Steinbach (17847521)

Mouse cyclicity and histological analysis of ovaries. by Valérie Bernard (2587648)